Lexicon Pharmaceuticals, Inc. (LXRX)
1.53
-0.14
(-8.38%)
USD |
NASDAQ |
Nov 20, 16:00
1.53
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Total Return Level : 1.53 for Nov. 20, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.53 |
| November 19, 2026 | 1.67 |
| November 18, 2026 | 1.72 |
| November 17, 2026 | 1.78 |
| November 16, 2026 | 1.75 |
| November 13, 2026 | 1.79 |
| November 12, 2026 | 1.82 |
| November 11, 2026 | 1.87 |
| November 10, 2026 | 1.86 |
| November 09, 2026 | 1.82 |
| November 06, 2026 | 1.78 |
| November 05, 2026 | 1.61 |
| November 04, 2026 | 1.48 |
| November 03, 2026 | 1.46 |
| November 02, 2026 | 1.44 |
| October 30, 2026 | 1.42 |
| October 29, 2026 | 1.48 |
| October 28, 2026 | 1.485 |
| October 27, 2026 | 1.48 |
| October 26, 2026 | 1.45 |
| October 23, 2026 | 1.42 |
| October 22, 2026 | 1.49 |
| October 21, 2026 | 1.56 |
| October 20, 2026 | 1.58 |
| October 19, 2026 | 1.55 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.52 |
| October 15, 2026 | 1.65 |
| October 14, 2026 | 1.60 |
| October 13, 2026 | 1.61 |
| October 12, 2026 | 1.65 |
| October 09, 2026 | 1.68 |
| October 08, 2026 | 1.76 |
| October 07, 2026 | 1.76 |
| October 06, 2026 | 1.75 |
| October 05, 2026 | 1.74 |
| October 02, 2026 | 1.82 |
| October 01, 2026 | 1.82 |
| September 30, 2026 | 1.875 |
| September 29, 2026 | 1.88 |
| September 28, 2026 | 1.90 |
| September 25, 2026 | 1.795 |
| September 24, 2026 | 1.86 |
| September 23, 2026 | 2.06 |
| September 22, 2026 | 2.18 |
| September 21, 2026 | 2.04 |
| September 18, 2026 | 2.05 |
| September 17, 2026 | 2.035 |
| September 16, 2026 | 2.02 |
| September 15, 2026 | 2.01 |
| September 14, 2026 | 1.98 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Bristol Myers Squibb Co. | 224.76 |
| ANI Pharmaceuticals, Inc. | 68.55 |
| Corcept Therapeutics, Inc. | 63.62 |
| Veru, Inc. | 2.268 |
| Johnson & Johnson | 645.40 |